Ena Respiratory
About:
Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.
Website: https://enarespiratory.com/
Twitter/X: innavac
Top Investors: AustralianSuper, U.S. Department of Defense, Hostplus, Brandon Capital, Minderoo Foundation
Description:
Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines. Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterial dissemination to the lungs.
$41.5M
$1M to $10M
Melbourne, Victoria, Australia
2014-01-01
info(AT)innavac.com
Christophe Demaison
11-50
2024-05-07
Private
© 2025 bioDAO.ai